Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Gilead Sciences Inc.

Maryland

Hybrid

USD 180.000 - 280.000

Vollzeit

14 Tage+

Erhalte eine Antwort von diesem Arbeitgeber

Dein Lebenslauf und dein Anschreiben, genau auf das zugeschnitten, was gesucht wird.

Schaffe es an den ATS-Filtern vorbei

Zusammenfassung

Gilead Sciences Inc. is seeking a Director, Global Value & Access Strategy for its cell-therapy autoimmune portfolio.

This hybrid, office-based role will be based in California (El Segundo, Thousand Oaks or Foster City) and reports to the Senior Director, GVA Lead, Lymphoma, Autoimmune and Solid Tumors/Pipeline. You will lead global value and access strategies, integrating payer perspectives into development decisions and launch planning across major markets.

Qualifikationen

  • Experience leading global market access strategies for biopharma or cell-therapy programs.
  • Strong collaboration with cross-functional teams across Clinical Development, HEOR/RWE and Regulatory.
  • Ability to shape payer perspectives and launch planning for autoimmune indications.

Aufgaben

  • Lead the development and execution of global market access strategies from early development to launch.
  • Collaborate with regional teams to develop integrated global-to-local reimbursement plans.
  • Shape evidence generation strategies to support pricing, HTA submissions and formulary access.
  • Provide strategic leadership on US market access dynamics for autoimmune programs.
  • Ensure payer perspectives are incorporated into development milestones and governance.

Jobbeschreibung

We're here for one reason and one reason only - to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We've made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.

Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfill their aspirations. Join Kite and help create more tomorrows.

Job Description

We are seeking a Director, Global Value & Access Strategy (GVAS), Cell-therapy Autoimmune. This role reports to the Senior Director, GVA Lead, Lymphoma, Autoimmune and Solid Tumors/Pipeline.

This role will be office-based/hybrid (3 days onsite) in El Segundo or Thousand Oaks or Foster City, CA.

In this position, you will be a critical Global Value & Access partner for Kite's growing autoimmune cell therapy portfolio. You will lead the development and execution of global market access strategies to support early and late-stage development programs, while preparing for future launches of transformative cell therapies across autoimmune diseases.

You will work closely with Global Clinical Development, Medical Affairs, HEOR/RWE, Commercial, Regulatory Affairs and regional Access teams to ensure payer perspectives are incorporated into development decisions and launch planning. You will play a key role in shaping evidence generation strategies that support differentiated value propositions, reimbursement, and patient access across major global markets.

Key Responsibilities
Strategic Market Access Leadership
  • Serve as the Global Market Access representative for assigned autoimmune programs and contribute to cross-functional conversations.
  • In the Value Access Sub-Team, you will be leading and partnering with the Global and Regional functions of Value Access, HEOR/RWE and commercial to ensure efficient integration of Access input into the Portfolio Strategy.
  • Lead the development of global value and access strategies across the product lifecycle, from early development through launch and lifecycle management.
  • Ensure payer, HTA, and health system perspectives are reflected in development, evidence generation, pricing, and commercialization strategies.
  • Partner with regional and country access teams to develop integrated global-to-local reimbursement strategies.
Asset Development and Evidence Generation
  • Analyze market access trends, evolving reimbursement requirements, competitive dynamics, and health system considerations across major markets including the US, EU5, Canada, Australia, and Japan.
  • Provide market access input into target product profiles, clinical development plans, endpoint selection, comparator strategy, study design, and evidence generation plans.
  • Advise development teams on evidence requirements needed to support future reimbursement, pricing, and formulary access decisions.
  • Ensure access-relevant considerations are incorporated into development milestones and governance decisions.
Value Demonstration and HEOR Partnership
  • Partner with Clinical, HEOR, RWE and Medical Affairs to develop and execute early payer engagement and HTA scientific advice strategies across multiple autoimmune indications, ensuring payer perspectives are incorporated into evidence generation and development plans.
  • Provide strategic leadership on US market access dynamics across autoimmune indications, including payer formulary management, utilization management (e.g., step edits and prior authorization), and rebate contracting strategies, ensuring these considerations are proactively incorporated in development,
Hol dir deinen kostenlosen, vertraulichen Lebenslauf-Check.

oder ziehe deine Datei hierhin.

Similar jobs

Ähnliche Jobs, die dir auch gefallen könnten

Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Gilead Sciences, Inc. • El Segundo (CA)

Hybrid
USD 226.000 - 293.000
Benefits package
Discretionary bonus
Stock-based long-term incentives
+1
Global Value & Access Director, Autoimmune Cell Therapy
Global Value & Access Director, Autoimmune Cell Therapy

Gilead Sciences, Inc. • El Segundo (CA)

Hybrid
USD 226.000 - 293.000
Benefits package
Discretionary bonus
Stock-based long-term incentives
+1
Director, Global Value & Access for Autoimmune (Hybrid)
Director, Global Value & Access for Autoimmune (Hybrid)

Kite Pharma, Inc. • Parsippany-Troy Hills (NJ)

Hybrid
USD 206.000 - 266.000
Medical insurance
Dental insurance
Vision insurance
+4
Global Access Director, Autoimmune Cell Therapies
Global Access Director, Autoimmune Cell Therapies

Kite Pharma, Inc. • San Francisco (CA)

Hybrid
USD 226.000 - 293.000
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Kite Pharma • Parsippany-Troy Hills (NJ)

Hybrid
USD 206.000 - 266.000
Medical insurance
Dental insurance
Vision insurance
+4
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Kite Pharma, Inc. • San Francisco (CA)

Hybrid
USD 226.000 - 293.000
Global Value & Access Director, Autoimmune Cell Therapy
Global Value & Access Director, Autoimmune Cell Therapy

Gilead Sciences Inc. • Maryland

Hybrid
USD 180.000 - 280.000
Director, US Payer & Value Marketing
Director, US Payer & Value Marketing

Kite Pharma • San Francisco (CA)

Hybrid
USD 206.000 - 293.000
Benefits package
Discretionary bonus
Stock-based incentives
+1
Director, US Payer & Value Marketing
Director, US Payer & Value Marketing

Kite Pharma • Parsippany-Troy Hills (NJ)

Hybrid
USD 206.000 - 293.000
Discretionary annual bonus
Discretionary stock-based incentives
Paid time off
Director, US Payer & Value Marketing
Director, US Payer & Value Marketing

Kite Pharma • Santa Monica (CA)

Hybrid
USD 206.000 - 266.000
Discretionary annual bonus
Discretionary stock-based incentives
Paid time off
+1